Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSDAQ 24671038 approvals

T&R Biofab Co., Ltd

Official website

Founded in 2013 and KOSDAQ-listed in 2018, T&R Biofab commercializes 3D bioprinting systems, bioinks, and biodegradable scaffolds.

As of 2026-10-11, T&R Biofab Co., Ltd has 36 Korean MFDS device approvals, 2 US FDA clearances/approvals, 58 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

T&R Biofab was founded in 2013 and listed on KOSDAQ in 2018 as a regenerative medicine company. It has commercialized its 3D bioprinting systems, bioinks, and biodegradable scaffolds, and its cosmetics line includes HA (hyaluronic acid) film, HA mask packs, Blisspack HA balls, and PDRN serum. Its business spans three segments—regenerative medicine, bio-surgical solutions, and cosmetics—pairing near-term revenue from bio-surgical solutions with cosmetics as a new growth driver.

Products & technology

  • 3D Bioprinting System3D bioprinting system using biocompatible materials and living cells to build layered 3D structures, including cell printing
  • BioinkHydrogel material essential for cell printing that keeps loaded living cells viable and functional after printing
  • Biodegradable ScaffoldTissue-regenerating scaffold produced with the 3D bioprinting system; degrades in the body and allows tissue ingrowth for reconstruction
  • 3D OrganoidOrgan-like 3D structure for in vitro testing
  • 3D Cell TherapyCell therapy using biomaterials to mimic a patient's 3D tissue structure, applying or injecting living cells directly
  • HA FilmHyaluronic acid (HA)-based cosmetic film
  • HA Mask PackHyaluronic acid (HA)-based cosmetic mask pack
  • Blisspack HA BallFreeze-dried HA (hyaluronic acid) ball cosmetic product in blister packaging
  • PDRN SerumPDRN (polydeoxyribonucleotide)-based cosmetic serum

Regulatory approvals

data.go.kr · openFDA

36 Korean MFDS device approvals · 2014–2026 / 2 US FDA 510(k) · 2023–2026

  • MFDSGraft/prosthesis, biomaterial2026-09-08
    Product approval · Class 4제허 26-677 호
  • FDATnR Cranial Implant2026-07-30
    510(k) · TraditionalNeurologyK251959
  • MFDSSurgical supplies2026-01-06
    Product approval · Class 1제신 26-11 호
  • MFDSMesh, polymeric, biodegradable2025-12-09
    Product approval · Class 4제허 25-829 호
  • MFDSHemostat, internal, absorbable2025-09-12
    Product approval · Class 4제허 25-637 호
  • MFDSHemostat, internal, absorbable2025-07-02
    Product approval · Class 4제허 25-434 호
  • MFDSDressing, occlusive, hydrogel2025-06-26
    Product approval · Class 2제인 25-4570 호
  • MFDSHemostat, internal, absorbable2025-05-09
    Product approval · Class 4제허 25-302 호
  • MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2024-11-20
    Product approval · Class 3제허 24-817 호
  • MFDSDressing, occlusive, hydrogel2024-11-07
    Product approval · Class 2제인 24-1000 호
  • MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2024-10-22
    Product approval · Class 3제허 24-719 호
  • MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2024-10-15
    Product approval · Class 3제허 24-697 호
Show 26 more
  • MFDSDressing, occlusive, hydrogel2024-08-14
    Product approval · Class 2제인 24-775 호
  • MFDSGraft/prosthesis, biomaterial2024-07-10
    Product approval · Class 4제허 24-467 호
  • MFDSGraft/prosthesis, biomaterial2024-07-10
    Product approval · Class 4제허 24-466 호
  • MFDSDressing, high-absorbent, foam/sheet/liquid/powder2024-01-08
    Product approval · Class 2제인 24-22 호
  • FDATHERMOCLICK2023-12-05
    510(k) · TraditionalGeneral HospitalK222057
  • MFDSDressing, occlusive, hydrogel2023-08-30
    Product approval · Class 2제인 23-5052 호
  • MFDSTissue supplement, collagen2023-04-26
    Product approval · Class 4제허 23-542 호
  • MFDSMesh, polymeric, biodegradable2023-04-03
    Product approval · Class 4제허 23-464 호
  • MFDSDressing, occlusive, hydrogel2022-03-24
    Product approval · Class 2제인 22-4233 호
  • MFDSCranioplasty plate, biological/biodegradable2021-02-19
    Product approval · Class 4제허 21-126 호
  • MFDSBarrier, intra oral, resorbable2020-11-12
    Product approval · Class 4제허 20-961 호
  • MFDSSplint, mouldable2020-09-11
    Product approval · Class 1제신 20-1401 호
  • MFDSThermometer, electronic, infrared, skin2020-03-16
    Product approval · Class 2제인 20-4206 호
  • MFDSTissue reconstructive material, synthetic, polymer, absorbable2018-11-08
    Product approval · Class 4제허 18-725 호
  • MFDSCranioplasty plate, biological/biodegradable2017-08-24
    Product approval · Class 4제허 17-651 호
  • MFDSCranioplasty plate, biological/biodegradable2017-08-24
    Product approval · Class 4제허 17-650 호
  • MFDSCranioplasty plate, biological/biodegradable2017-08-24
    Product approval · Class 4제허 17-648 호
  • MFDSCranioplasty plate, biological/biodegradable2017-08-24
    Product approval · Class 4제허 17-649 호
  • MFDSThermometer, electronic, infrared, ear2017-06-01
    Product approval · Class 2제인 17-4428 호
  • MFDSCranioplasty plate, biological/biodegradable2017-05-26
    Product approval · Class 4제허 17-351 호
  • MFDSCranioplasty plate, biological/biodegradable2017-05-12
    Product approval · Class 4제허 17-312 호
  • MFDSBarrier, intra oral, resorbable2017-02-16
    Product approval · Class 4제허 17-117 호
  • MFDSBarrier, intra oral, resorbable2016-11-03
    Product approval · Class 4제허 16-802 호
  • MFDSCranioplasty plate, biological/biodegradable2016-10-10
    Product approval · Class 4제허 16-745 호
  • MFDSThermometer, electronic, infrared, skin2016-05-16
    Product approval · Class 2제인 16-4397 호
  • MFDSCranioplasty plate, biological/biodegradable2014-07-16
    Product approval · Class 4제허 14-1337 호

Global clinical trials

ClinicalTrials.gov · sponsor-matched

Key disclosures

KRX KIND via OpenDART
Show 2 more events

Publications

PubMed · affiliation-matched
Show 48 more publications

Patents

KIPRIS · applicant-matched
Show 210 more patents

AI reads

MAA server logs · IP-verified
68
Times AI engines pulled T&R Biofab Co., Ltd's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

3
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

65
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

7
live 1
Last 7 days
51
live 2
Last 30 days
68
live 3
All time
  • OpenAIChatGPT-Userlive3
  • OpenAIOAI-SearchBot52
  • GoogleGoogleOther6
  • PerplexityPerplexityBot4
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for T&R Biofab Co., Ltd and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsBiotech & Drug Discovery

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

HANS BIOMED CORPORATION3 shared

KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.

Samyang Biopharm Corporation3 shared

Founded and KOSPI-listed in 2025, Samyang Biopharm develops medical devices, pharmaceuticals, and new drug candidates.

OSTEONIC Co., Ltd.3 shared

Established in 2012 and listed on KOSDAQ in 2018, Osteonic manufactures implants for the CMF, Trauma, Sports Medicine, and Spine categories.

Wonbiogen Co.,Ltd.3 shared

Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.

DongBang Medical Co., Ltd.2 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

GC Medical Science Corporation2 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

METABIOMED.CO.,LTD2 shared

KOSDAQ-listed medical device company manufacturing synthetic bioresorbable suture yarn and dental root canal filling materials.

PharmaResearch Co., Ltd.2 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

DENTIS CO.,LTD2 shared

Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.

BNC KOREA, Inc.2 shared

Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.

CELLUMED CO., LTD.2 shared

KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.

GC Biopharma Corp.1 shared

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition